KIMBERLY LANE: Open Payments
NPI 1457670119 · LA MESA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$326 in 13 payments from 8 companies in 2025. Trend: 2023 $1,371 · 2024 $584 · 2025 $326
Food & beverage: $326
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 6 | $127 |
| Blue Earth Diagnostics | 1 | $41 |
| UROGEN PHARMA, INC. | 1 | $41 |
| Antares Pharma, Inc. | 1 | $33 |
| Teleflex LLC | 1 | $23 |
| Myriad Genetic Laboratories, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $21 |
| Photocure Inc | 1 | $20 |
Products named: GEMTESA, POSLUMA, JELMYTO, XYOSTED, BARRIGEL, PROLARIS, XTANDI, CYSVIEW.
Industry payments across CA — which companies pay providers there.
